Has Larue Penny received payments from drug or device companies?

Yes. Drug and device makers reported $1,613 in general payments to Larue Penny across 92 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Larue Penny did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Larue Penny come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Larue Penny

Pediatrics · Alpharetta, GANPI 1023099942

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 90.7% of the total across 92 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Tris Pharma Inc at 25.9% of the total. Among pediatrics clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,613in general payments, 2019–2025

Across 92 payments — averaging $17.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Tris Pharma Inc$418
Corium, LLC$326
Comsort, Inc$150
Takeda Pharmaceuticals U.S.A., Inc.$107
Ironshore Pharmaceuticals Inc.$88
Kaleo, Inc.$72
plus $453 from 12 others

What the payments were for

Consulting fees$1509%
Food & beverage$1,46391%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Tris Pharma Inc	24	$418
Corium, LLC	23	$326
Comsort, Inc	1	$150
Takeda Pharmaceuticals U.S.A., Inc.	7	$107
Ironshore Pharmaceuticals Inc.	4	$88
Kaleo, Inc.	5	$72
Sanofi Pasteur Inc.	3	$71
Neos Therapeutics, LP	4	$57
Arbor Pharmaceuticals, Inc.	4	$56
Merck	4	$53
Supernus Pharmaceuticals, Inc.	3	$48
Alk-abello, Inc	2	$33
Cranial Technologies, Inc	2	$31
Adlon Therapeutics L.p.	2	$29
Collegium Pharmaceutical, Inc.	1	$24
Sanofi-aventis U.S. LLC	1	$19
Seqirus USA Inc	1	$17
Novo Nordisk	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

GARDASIL$150

How this compares

$1,613 in reported general payments places this provider in the 90th percentile of 2,111 pediatrics providers in Georgia.

See all pediatrics providers in Georgia →

Other pediatrics in Alpharetta

Edward SalzbergAlpharetta$9K
Amir AshrafiAtlanta$563K
Sandra ArmsteadLithonia$424K
Satheesh ChonatAtlanta$147K
Karen ZimowskiAtlanta$139K
F CantrellMarietta$129K
Iyabode Akinsanya-BeysolowAtlanta$103K
Lauren MiddlebrooksAtlanta$71K
Rebecca EmoryAtlanta$40K
Mark GriffithsAtlanta$34K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →